What is the current valuation of the Contraceptive Drugs and Devices Market?

The market valuation was 47.17 USD Billion in 2024. Read More

What is the projected market size for the Contraceptive Drugs and Devices Market by 2035?

The market is projected to reach 75.03 USD Billion by 2035. Read More

What is the expected CAGR for the Contraceptive Drugs and Devices Market during the forecast period 2025 - 2035?

The expected CAGR is 4.31% during the forecast period. Read More

Which companies are considered key players in the Contraceptive Drugs and Devices Market?

Key players include Bayer AG, Pfizer Inc, Merck & Co., Inc., and others. Read More

What segment of contraceptive methods had the highest valuation in 2024?

Oral Contraceptives had the highest valuation at 12.0 USD Billion in 2024. Read More

How do contraceptive implants perform in terms of market valuation?

Contraceptive Implants had a valuation of 8.0 USD Billion in 2024. Read More

What is the market valuation for intrauterine devices in 2024?

Intrauterine Devices had a market valuation of 10.0 USD Billion in 2024. Read More

Which distribution channel is expected to show significant growth by 2035?

Retail Pharmacies are projected to grow from 15.0 USD Billion in 2024 to 24.0 USD Billion by 2035. Read More

What demographic segment is projected to have the highest market valuation by 2035?

Adults are projected to have the highest valuation, increasing from 20.0 USD Billion in 2024 to 30.0 USD Billion by 2035. Read More

What mode of administration is expected to see the most growth in the Contraceptive Drugs and Devices Market?

Injectable contraceptives are expected to grow from 10.0 USD Billion in 2024 to 15.0 USD Billion by 2035. Read More

Contraceptive Drugs Devices Market

Contraceptive Drugs and Devices Market Research Report: Size, Share, Trend Analysis By Product Type (Oral Contraceptives, Contraceptive Implants, Intrauterine Devices, Contraceptive Injections, Condoms), By Mode of Administration (Oral, Injectable, Implantable, Topical, Intrauterine), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, Supermarkets), By Demographics (Adolescents, Adults, Married Couples, Unmarried Couples) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

4.31%

2024 Market Size

$ 47.17 Billion

2035 Market Size

$ 75.03 Billion

Healthcare ● Updated August 2026 Report ID: MRFR/HC/41795-HCR | Pages: 200 | Author: Satyendra Maurya, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Type (USD Billion)
  1. 4.1.1 Oral Contraceptives
  2. 4.1.2 Contraceptive Implants
  3. 4.1.3 Intrauterine Devices
  4. 4.1.4 Contraceptive Injections
  5. 4.1.5 Condoms
2. 4.2 Healthcare, BY Mode of Administration (USD Billion)
  1. 4.2.1 Oral
  2. 4.2.2 Injectable
  3. 4.2.3 Implantable
  4. 4.2.4 Topical
  5. 4.2.5 Intrauterine
3. 4.3 Healthcare, BY Distribution Channel (USD Billion)
  1. 4.3.1 Hospital Pharmacies
  2. 4.3.2 Retail Pharmacies
  3. 4.3.3 Online Pharmacies
  4. 4.3.4 Drug Stores
  5. 4.3.5 Supermarkets
4. 4.4 Healthcare, BY Demographics (USD Billion)
  1. 4.4.1 Adolescents
  2. 4.4.2 Adults
  3. 4.4.3 Married Couples
  4. 4.4.4 Unmarried Couples
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Bayer AG (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Pfizer Inc (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Merck & Co., Inc. (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Teva Pharmaceutical Industries Ltd. (IL)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 HRA Pharma (FR)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Mylan N.V. (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Johnson & Johnson (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Bristol-Myers Squibb Company (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TYPE
4. 6.4 US MARKET ANALYSIS BY MODE OF ADMINISTRATION
5. 6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 US MARKET ANALYSIS BY DEMOGRAPHICS
7. 6.7 CANADA MARKET ANALYSIS BY TYPE
8. 6.8 CANADA MARKET ANALYSIS BY MODE OF ADMINISTRATION
9. 6.9 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
10. 6.10 CANADA MARKET ANALYSIS BY DEMOGRAPHICS
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY TYPE
13. 6.13 GERMANY MARKET ANALYSIS BY MODE OF ADMINISTRATION
14. 6.14 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
15. 6.15 GERMANY MARKET ANALYSIS BY DEMOGRAPHICS
16. 6.16 UK MARKET ANALYSIS BY TYPE
17. 6.17 UK MARKET ANALYSIS BY MODE OF ADMINISTRATION
18. 6.18 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
19. 6.19 UK MARKET ANALYSIS BY DEMOGRAPHICS
20. 6.20 FRANCE MARKET ANALYSIS BY TYPE
21. 6.21 FRANCE MARKET ANALYSIS BY MODE OF ADMINISTRATION
22. 6.22 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
23. 6.23 FRANCE MARKET ANALYSIS BY DEMOGRAPHICS
24. 6.24 RUSSIA MARKET ANALYSIS BY TYPE
25. 6.25 RUSSIA MARKET ANALYSIS BY MODE OF ADMINISTRATION
26. 6.26 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
27. 6.27 RUSSIA MARKET ANALYSIS BY DEMOGRAPHICS
28. 6.28 ITALY MARKET ANALYSIS BY TYPE
29. 6.29 ITALY MARKET ANALYSIS BY MODE OF ADMINISTRATION
30. 6.30 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
31. 6.31 ITALY MARKET ANALYSIS BY DEMOGRAPHICS
32. 6.32 SPAIN MARKET ANALYSIS BY TYPE
33. 6.33 SPAIN MARKET ANALYSIS BY MODE OF ADMINISTRATION
34. 6.34 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
35. 6.35 SPAIN MARKET ANALYSIS BY DEMOGRAPHICS
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY MODE OF ADMINISTRATION
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY DEMOGRAPHICS
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY TYPE
42. 6.42 CHINA MARKET ANALYSIS BY MODE OF ADMINISTRATION
43. 6.43 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
44. 6.44 CHINA MARKET ANALYSIS BY DEMOGRAPHICS
45. 6.45 INDIA MARKET ANALYSIS BY TYPE
46. 6.46 INDIA MARKET ANALYSIS BY MODE OF ADMINISTRATION
47. 6.47 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
48. 6.48 INDIA MARKET ANALYSIS BY DEMOGRAPHICS
49. 6.49 JAPAN MARKET ANALYSIS BY TYPE
50. 6.50 JAPAN MARKET ANALYSIS BY MODE OF ADMINISTRATION
51. 6.51 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
52. 6.52 JAPAN MARKET ANALYSIS BY DEMOGRAPHICS
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY MODE OF ADMINISTRATION
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY DEMOGRAPHICS
57. 6.57 MALAYSIA MARKET ANALYSIS BY TYPE
58. 6.58 MALAYSIA MARKET ANALYSIS BY MODE OF ADMINISTRATION
59. 6.59 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
60. 6.60 MALAYSIA MARKET ANALYSIS BY DEMOGRAPHICS
61. 6.61 THAILAND MARKET ANALYSIS BY TYPE
62. 6.62 THAILAND MARKET ANALYSIS BY MODE OF ADMINISTRATION
63. 6.63 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL
64. 6.64 THAILAND MARKET ANALYSIS BY DEMOGRAPHICS
65. 6.65 INDONESIA MARKET ANALYSIS BY TYPE
66. 6.66 INDONESIA MARKET ANALYSIS BY MODE OF ADMINISTRATION
67. 6.67 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
68. 6.68 INDONESIA MARKET ANALYSIS BY DEMOGRAPHICS
69. 6.69 REST OF APAC MARKET ANALYSIS BY TYPE
70. 6.70 REST OF APAC MARKET ANALYSIS BY MODE OF ADMINISTRATION
71. 6.71 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL
72. 6.72 REST OF APAC MARKET ANALYSIS BY DEMOGRAPHICS
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY TYPE
75. 6.75 BRAZIL MARKET ANALYSIS BY MODE OF ADMINISTRATION
76. 6.76 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL
77. 6.77 BRAZIL MARKET ANALYSIS BY DEMOGRAPHICS
78. 6.78 MEXICO MARKET ANALYSIS BY TYPE
79. 6.79 MEXICO MARKET ANALYSIS BY MODE OF ADMINISTRATION
80. 6.80 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL
81. 6.81 MEXICO MARKET ANALYSIS BY DEMOGRAPHICS
82. 6.82 ARGENTINA MARKET ANALYSIS BY TYPE
83. 6.83 ARGENTINA MARKET ANALYSIS BY MODE OF ADMINISTRATION
84. 6.84 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
85. 6.85 ARGENTINA MARKET ANALYSIS BY DEMOGRAPHICS
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY MODE OF ADMINISTRATION
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEMOGRAPHICS
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY MODE OF ADMINISTRATION
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY DEMOGRAPHICS
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY MODE OF ADMINISTRATION
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY DEMOGRAPHICS
99. 6.99 REST OF MEA MARKET ANALYSIS BY TYPE
100. 6.100 REST OF MEA MARKET ANALYSIS BY MODE OF ADMINISTRATION
101. 6.101 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
102. 6.102 REST OF MEA MARKET ANALYSIS BY DEMOGRAPHICS
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY MODE OF ADMINISTRATION, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY MODE OF ADMINISTRATION, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY DEMOGRAPHICS, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY DEMOGRAPHICS, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.2.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.3.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.3.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.4.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.4.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.5.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.5.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.6.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.6.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.7.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.7.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.8.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.8.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.9.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.9.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.10.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.10.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.11.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.11.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.12.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.12.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.13.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.13.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.14.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.14.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.15.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.15.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.16.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.16.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.17.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.17.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.18.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.18.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.19.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.19.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.20.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.20.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.21.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.21.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.22.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.22.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.23.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.23.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.24.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.24.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.25.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.25.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.26.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.26.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.27.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.27.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.28.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.28.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.29.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.29.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.30.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.30.4 BY DEMOGRAPHICS, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Contraceptive Drugs Devices Market Segmentation

Contraceptive Drugs Devices Market By Type (USD Billion, 2025-2035)

Oral Contraceptives
Contraceptive Implants
Intrauterine Devices
Contraceptive Injections
Condoms

Contraceptive Drugs Devices Market By Mode of Administration (USD Billion, 2025-2035)

Oral
Injectable
Implantable
Topical
Intrauterine

Contraceptive Drugs Devices Market By Distribution Channel (USD Billion, 2025-2035)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Supermarkets

Contraceptive Drugs Devices Market By Demographics (USD Billion, 2025-2035)

Adolescents
Adults
Married Couples
Unmarried Couples

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”